Currently DM is managed by insulin and oral hypoglycemic agents including sulfonylureas, biguanides, PPAR’s etc. Long term administration of these drugs may cause undesired effects and reduce the quality of life in diabetic patients. The gene discussed is INS; the disease is diabetes mellitus.